En español
NIDA

Menu

Panel Members: Washington, DC Location, April 2011

Long Day's Journey into Night

By Eugene O'Neill

Georgetown Location Panel Members:

Jeffrey Baxter, MD

Dr. Jeffrey Baxter is an assistant professor in the Department of Family Medicine at the University of Massachusetts Medical School. He is board certified in Family Medicine and Addiction Medicine and is the medical director for the Spectrum Health Systems network of methadone maintenance programs and the UMASS Community Health Link adult and adolescent detoxification units in Massachusetts. He also consults for the UMASS Correctional Health Program and the Massachusetts State Department of Corrections on addiction treatment issues for incarcerated populations.

Dr. Baxter's areas of clinical and educational specialty include the treatment of opiate dependence and the interface between chronic pain and addiction. He is a mentor with SAMHSA-funded Physician Clinical Support Service (PCSS), a nationwide network that provides clinical support to clinicians offering buprenorphine treatment and pain management with opioid medications. He is also working with the NIDA Centers of Excellence in Physician Information Program (NIDA CoE) developing curricula resource materials to educate medical providers and trainees in the safer use of opioid medications in the treatment of pain.

Judith Martin, MD

Dr. Judith Martin is an addiction specialist who has worked with opioid-addicted patients and their families for over twenty years. She has provided training about methadone and buprenorphine treatment of addiction to physicians and clinic staff from many states. She is currently the immediate past president of the California Society of Addiction Medicine, and this year she was elected to the board of directors for the American Society of Addiction Medicine. She is medical director of the BAART Turk Street Clinic. The Turk Street Clinic offers addiction treatment, mental health services, and primary care in San Francisco's Tenderloin neighborhood. Most of the patients at Turk Street Clinic are indigent and many are homeless or marginally housed.

ASAM Location Panel Members:

Jeffrey Baxter, MD

Dr. Jeffrey Baxter is an assistant professor in the Department of Family Medicine at the University of Massachusetts Medical School. He is board certified in Family Medicine and Addiction Medicine and is the medical director for the Spectrum Health Systems network of methadone maintenance programs and the UMASS Community Health Link adult and adolescent detoxification units in Massachusetts. He also consults for the UMASS Correctional Health Program and the Massachusetts State Department of Corrections on addiction treatment issues for incarcerated populations.

Dr. Baxter's areas of clinical and educational specialty include the treatment of opiate dependence and the interface between chronic pain and addiction. He is a mentor with SAMHSA-funded Physician Clinical Support Service (PCSS), a nationwide network that provides clinical support to clinicians offering buprenorphine treatment and pain management with opioid medications. He is also working with the NIDA Centers of Excellence in Physician Information Program (NIDA CoE) developing curricula resource materials to educate medical providers and trainees in the safer use of opioid medications in the treatment of pain.

Robert E. Taylor, MD, PhD

Dr. Robert E. Taylor is an academician, physician, clinical pharmacologist, researcher and administrator. He earned a B.S. (Pharmacy) and M.S. (Pharmacology) degree from Butler University, Indianapolis Indiana; a Ph.D. degree (Pharmacology/Toxicology) from Purdue University, W. Lafayette Indiana; and a M.D. degree from Vanderbilt University School of Medicine, Nashville Tennessee, where he also completed residency training in Internal Medicine. He is Professor of Pharmacology, Medicine and Psychiatry. From 1992-2008, he served as Chairman, Department of Pharmacology, Howard University College of Medicine and as Director, Division of Clinical Pharmacology, Howard University Hospital. On August 1, 2005, Dr. Taylor was appointed Interim Dean of the College of Medicine and confirmed Dean in January 2008. An expert in pharmacokinetics, cardiovascular and clinical pharmacology, Dr. Taylor is Board Certified in Internal Medicine.

Nora D. Volkow, M.D.

Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. NIDA supports most of the world's research on the health aspects of drug abuse and addiction.

Dr. Volkow's work has been instrumental in demonstrating that drug addiction is a disease of the human brain. As a research psychiatrist and scientist, Dr. Volkow pioneered the use of brain imaging to investigate the toxic effects of drugs and their addictive properties. Her studies have documented changes in the dopamine system affecting the actions of frontal brain regions involved with motivation, drive, and pleasure and the decline of brain dopamine function with age. She has also made important contributions to the neurobiology of obesity, ADHD, and the behavioral changes that occur with aging.

Dr. Volkow was born in Mexico, attended the Modern American School, and earned her medical degree from the National University of Mexico in Mexico City, where she received the Premio Robins award for best medical student of her generation. Her psychiatric residency was at New York University, where she earned the Laughlin Fellowship Award as one of the 10 Outstanding Psychiatric Residents in the USA.

Dr. Volkow spent most of her professional career at the Department of Energy's Brookhaven National Laboratory (BNL) in Upton, New York, where she held several leadership positions including Director of Nuclear Medicine, Chairman of the Medical Department, and Associate Director for Life Sciences. In addition, Dr. Volkow was a professor in the Department of Psychiatry and Associate Dean of the Medical School at the State University of New York (SUNY)-Stony Brook.

Dr. Volkow has published more than 440 peer-reviewed articles and more than 75 book chapters and nonpeer reviewed manuscripts, and has also edited three books on the use of neuroimaging in studying mental and addictive disorders.

During her professional career, Dr. Volkow has been the recipient of multiple awards, including her selection for membership in the Institute of Medicine in the National Academy of Sciences and the International Prize from the French Institute of Health and Medical Research for her pioneering work in brain imaging and addiction science. She was recently named one of Time Magazine's "Top 100 People Who Shape our World" and was included as one of the 20 people to watch by Newsweek magazine in its "Who's Next in 2007" feature. She was also included in Washingtonian Magazine's 2009 list of the "100 Most Powerful Women" and named "Innovator of the Year" by U.S. News & World Report in 2000.